Clinical Trials on Advanced Solid Neoplasms in Singapore
Total 1154 results
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
EDDC (Experimental Drug Development Centre), A*STAR...ParexelRecruiting
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsAustralia, Singapore
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
SingHealth PolyclinicsCompletedAdvanced Medical Directive, a Legal Document Signed in Advance to State Healthcare PreferencesSingapore
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | LymphomasSingapore
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...RecruitingNon-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid TumoursSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeNatera, Inc.; The N.1 Institute for Health (N.1)Recruiting
-
Kyowa Kirin Co., Ltd.Terminated
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
National University Hospital, SingaporeRecruiting
-
National University Hospital, SingaporeSchool of Computing, National University of Singapore; Cancer Science Institute...RecruitingSolid Organ MalignanciesSingapore
-
Otsuka Beijing Research InstituteCompletedMalignant Solid TumourSingapore
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
BayerRecruitingAdvanced Solid TumorsUnited States, Canada, Singapore, United Kingdom, Belgium
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Australia, Spain, United Kingdom, France, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1); Cancer Science Institute of SingaporeNot yet recruitingBreast Cancer | Solid Tumor | Gastrointestinal CancerSingapore
-
National University Hospital, SingaporeUnknownCancer (Advanced Stage)Singapore
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; ASLAN PharmaceuticalsActive, not recruiting
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
National Cancer Centre, SingaporeRecruiting
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
National University Hospital, SingaporeUnknownSolid Tumor CancerSingapore
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore